Global Amlodipine Besylate Market Research Report 2020


This report focuses on Amlodipine Besylate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Amlodipine Besylate market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Pfizer
    Mylan
    Dr. Reddy's Laboratories
    Apotex
    Teva Pharmaceutical
    Cipla
    Hikma Pharmaceuticals
    Strides Pharma
    Upsher-Smith Laboratories
    InvaGen Pharmaceuticals
    Sun Pharmaceutical
    Aurobindo Pharma
    Lupin Pharmaceuticals
    Zydus Pharmaceuticals
    Oxford Pharm
    Wockhardt
    Epic Pharma
    CR Pharmaceutical
    Alkem Laboratories
    MACLEODS

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    2.5mg Tablets
    5mg Tablets
    10mg Tablets

Segment by Application
    High Blood Pressure
    Heart Disease
Table of Contents

1 Amlodipine Besylate Market Overview
    1.1 Product Overview and Scope of Amlodipine Besylate
    1.2 Amlodipine Besylate Segment by Type
        1.2.1 Global Amlodipine Besylate Sales Growth Rate Comparison by Type (2021-2026)
        1.2.2 2.5mg Tablets
        1.2.3 5mg Tablets
        1.2.4 10mg Tablets
    1.3 Amlodipine Besylate Segment by Application
        1.3.1 Amlodipine Besylate Sales Comparison by Application: 2020 VS 2026
        1.3.2 High Blood Pressure
        1.3.3 Heart Disease
    1.4 Global Amlodipine Besylate Market Size Estimates and Forecasts
        1.4.1 Global Amlodipine Besylate Revenue 2015-2026
        1.4.2 Global Amlodipine Besylate Sales 2015-2026
        1.4.3 Amlodipine Besylate Market Size by Region: 2020 Versus 2026

2 Global Amlodipine Besylate Market Competition by Manufacturers
    2.1 Global Amlodipine Besylate Sales Market Share by Manufacturers (2015-2020)
    2.2 Global Amlodipine Besylate Revenue Share by Manufacturers (2015-2020)
    2.3 Global Amlodipine Besylate Average Price by Manufacturers (2015-2020)
    2.4 Manufacturers Amlodipine Besylate Manufacturing Sites, Area Served, Product Type
    2.5 Amlodipine Besylate Market Competitive Situation and Trends
        2.5.1 Amlodipine Besylate Market Concentration Rate
        2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
        2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    2.7 Primary Interviews with Key Amlodipine Besylate Players (Opinion Leaders)

3 Amlodipine Besylate Retrospective Market Scenario by Region
    3.1 Global Amlodipine Besylate Retrospective Market Scenario in Sales by Region: 2015-2020
    3.2 Global Amlodipine Besylate Retrospective Market Scenario in Revenue by Region: 2015-2020
    3.3 North America Amlodipine Besylate Market Facts & Figures by Country
        3.3.1 North America Amlodipine Besylate Sales by Country
        3.3.2 North America Amlodipine Besylate Sales by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Amlodipine Besylate Market Facts & Figures by Country
        3.4.1 Europe Amlodipine Besylate Sales by Country
        3.4.2 Europe Amlodipine Besylate Sales by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Amlodipine Besylate Market Facts & Figures by Region
        3.5.1 Asia Pacific Amlodipine Besylate Sales by Region
        3.5.2 Asia Pacific Amlodipine Besylate Sales by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Amlodipine Besylate Market Facts & Figures by Country
        3.6.1 Latin America Amlodipine Besylate Sales by Country
        3.6.2 Latin America Amlodipine Besylate Sales by Country
        3.6.3 Mexico
        3.6.3 Brazil
        3.6.3 Argentina
    3.7 Middle East and Africa Amlodipine Besylate Market Facts & Figures by Country
        3.7.1 Middle East and Africa Amlodipine Besylate Sales by Country
        3.7.2 Middle East and Africa Amlodipine Besylate Sales by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Amlodipine Besylate Historic Market Analysis by Type
    4.1 Global Amlodipine Besylate Sales Market Share by Type (2015-2020)
    4.2 Global Amlodipine Besylate Revenue Market Share by Type (2015-2020)
    4.3 Global Amlodipine Besylate Price Market Share by Type (2015-2020)
    4.4 Global Amlodipine Besylate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Amlodipine Besylate Historic Market Analysis by Application
    5.1 Global Amlodipine Besylate Sales Market Share by Application (2015-2020)
    5.2 Global Amlodipine Besylate Revenue Market Share by Application (2015-2020)
    5.3 Global Amlodipine Besylate Price by Application (2015-2020)

6 Company Profiles and Key Figures in Amlodipine Besylate Business
    6.1 Pfizer
        6.1.1 Corporation Information
        6.1.2 Pfizer Description, Business Overview and Total Revenue
        6.1.3 Pfizer Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.1.4 Pfizer Products Offered
        6.1.5 Pfizer Recent Development
    6.2 Mylan
        6.2.1 Mylan Amlodipine Besylate Production Sites and Area Served
        6.2.2 Mylan Description, Business Overview and Total Revenue
        6.2.3 Mylan Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.2.4 Mylan Products Offered
        6.2.5 Mylan Recent Development
    6.3 Dr. Reddy's Laboratories
        6.3.1 Dr. Reddy's Laboratories Amlodipine Besylate Production Sites and Area Served
        6.3.2 Dr. Reddy's Laboratories Description, Business Overview and Total Revenue
        6.3.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.3.4 Dr. Reddy's Laboratories Products Offered
        6.3.5 Dr. Reddy's Laboratories Recent Development
    6.4 Apotex
        6.4.1 Apotex Amlodipine Besylate Production Sites and Area Served
        6.4.2 Apotex Description, Business Overview and Total Revenue
        6.4.3 Apotex Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Apotex Products Offered
        6.4.5 Apotex Recent Development
    6.5 Teva Pharmaceutical
        6.5.1 Teva Pharmaceutical Amlodipine Besylate Production Sites and Area Served
        6.5.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
        6.5.3 Teva Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.5.4 Teva Pharmaceutical Products Offered
        6.5.5 Teva Pharmaceutical Recent Development
    6.6 Cipla
        6.6.1 Cipla Amlodipine Besylate Production Sites and Area Served
        6.6.2 Cipla Description, Business Overview and Total Revenue
        6.6.3 Cipla Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.6.4 Cipla Products Offered
        6.6.5 Cipla Recent Development
    6.7 Hikma Pharmaceuticals
        6.6.1 Hikma Pharmaceuticals Amlodipine Besylate Production Sites and Area Served
        6.6.2 Hikma Pharmaceuticals Description, Business Overview and Total Revenue
        6.6.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Hikma Pharmaceuticals Products Offered
        6.7.5 Hikma Pharmaceuticals Recent Development
    6.8 Strides Pharma
        6.8.1 Strides Pharma Amlodipine Besylate Production Sites and Area Served
        6.8.2 Strides Pharma Description, Business Overview and Total Revenue
        6.8.3 Strides Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.8.4 Strides Pharma Products Offered
        6.8.5 Strides Pharma Recent Development
    6.9 Upsher-Smith Laboratories
        6.9.1 Upsher-Smith Laboratories Amlodipine Besylate Production Sites and Area Served
        6.9.2 Upsher-Smith Laboratories Description, Business Overview and Total Revenue
        6.9.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.9.4 Upsher-Smith Laboratories Products Offered
        6.9.5 Upsher-Smith Laboratories Recent Development
    6.10 InvaGen Pharmaceuticals
        6.10.1 InvaGen Pharmaceuticals Amlodipine Besylate Production Sites and Area Served
        6.10.2 InvaGen Pharmaceuticals Description, Business Overview and Total Revenue
        6.10.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.10.4 InvaGen Pharmaceuticals Products Offered
        6.10.5 InvaGen Pharmaceuticals Recent Development
    6.11 Sun Pharmaceutical
        6.11.1 Sun Pharmaceutical Amlodipine Besylate Production Sites and Area Served
        6.11.2 Sun Pharmaceutical Amlodipine Besylate Description, Business Overview and Total Revenue
        6.11.3 Sun Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.11.4 Sun Pharmaceutical Products Offered
        6.11.5 Sun Pharmaceutical Recent Development
    6.12 Aurobindo Pharma
        6.12.1 Aurobindo Pharma Amlodipine Besylate Production Sites and Area Served
        6.12.2 Aurobindo Pharma Amlodipine Besylate Description, Business Overview and Total Revenue
        6.12.3 Aurobindo Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.12.4 Aurobindo Pharma Products Offered
        6.12.5 Aurobindo Pharma Recent Development
    6.13 Lupin Pharmaceuticals
        6.13.1 Lupin Pharmaceuticals Amlodipine Besylate Production Sites and Area Served
        6.13.2 Lupin Pharmaceuticals Amlodipine Besylate Description, Business Overview and Total Revenue
        6.13.3 Lupin Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.13.4 Lupin Pharmaceuticals Products Offered
        6.13.5 Lupin Pharmaceuticals Recent Development
    6.14 Zydus Pharmaceuticals
        6.14.1 Zydus Pharmaceuticals Amlodipine Besylate Production Sites and Area Served
        6.14.2 Zydus Pharmaceuticals Amlodipine Besylate Description, Business Overview and Total Revenue
        6.14.3 Zydus Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.14.4 Zydus Pharmaceuticals Products Offered
        6.14.5 Zydus Pharmaceuticals Recent Development
    6.15 Oxford Pharm
        6.15.1 Oxford Pharm Amlodipine Besylate Production Sites and Area Served
        6.15.2 Oxford Pharm Amlodipine Besylate Description, Business Overview and Total Revenue
        6.15.3 Oxford Pharm Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.15.4 Oxford Pharm Products Offered
        6.15.5 Oxford Pharm Recent Development
    6.16 Wockhardt
        6.16.1 Wockhardt Amlodipine Besylate Production Sites and Area Served
        6.16.2 Wockhardt Amlodipine Besylate Description, Business Overview and Total Revenue
        6.16.3 Wockhardt Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.16.4 Wockhardt Products Offered
        6.16.5 Wockhardt Recent Development
    6.17 Epic Pharma
        6.17.1 Epic Pharma Amlodipine Besylate Production Sites and Area Served
        6.17.2 Epic Pharma Amlodipine Besylate Description, Business Overview and Total Revenue
        6.17.3 Epic Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.17.4 Epic Pharma Products Offered
        6.17.5 Epic Pharma Recent Development
    6.18 CR Pharmaceutical
        6.18.1 CR Pharmaceutical Amlodipine Besylate Production Sites and Area Served
        6.18.2 CR Pharmaceutical Amlodipine Besylate Description, Business Overview and Total Revenue
        6.18.3 CR Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.18.4 CR Pharmaceutical Products Offered
        6.18.5 CR Pharmaceutical Recent Development
    6.19 Alkem Laboratories
        6.19.1 Alkem Laboratories Amlodipine Besylate Production Sites and Area Served
        6.19.2 Alkem Laboratories Amlodipine Besylate Description, Business Overview and Total Revenue
        6.19.3 Alkem Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.19.4 Alkem Laboratories Products Offered
        6.19.5 Alkem Laboratories Recent Development
    6.20 MACLEODS
        6.20.1 MACLEODS Amlodipine Besylate Production Sites and Area Served
        6.20.2 MACLEODS Amlodipine Besylate Description, Business Overview and Total Revenue
        6.20.3 MACLEODS Amlodipine Besylate Sales, Revenue and Gross Margin (2015-2020)
        6.20.4 MACLEODS Products Offered
        6.20.5 MACLEODS Recent Development

7 Amlodipine Besylate Manufacturing Cost Analysis
    7.1 Amlodipine Besylate Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Raw Materials Price Trend
       7.1.3 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Amlodipine Besylate
    7.4 Amlodipine Besylate Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Amlodipine Besylate Distributors List
    8.3 Amlodipine Besylate Customers

9 Market Dynamics
    9.1 Market Trends
    9.2 Opportunities and Drivers
    9.3 Challenges
    9.4 Porter's Five Forces Analysis

10 Global Market Forecast
    10.1 Global Amlodipine Besylate Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Amlodipine Besylate by Type (2021-2026)
        10.1.2 Global Forecasted Revenue of Amlodipine Besylate by Type (2021-2026)
    10.2 Amlodipine Besylate Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Amlodipine Besylate by Application (2021-2026)
        10.2.2 Global Forecasted Revenue of Amlodipine Besylate by Application (2021-2026)
    10.3 Amlodipine Besylate Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Amlodipine Besylate by Region (2021-2026)
        10.3.2 Global Forecasted Revenue of Amlodipine Besylate by Region (2021-2026)
    10.4 North America Amlodipine Besylate Estimates and Projections (2021-2026)
    10.5 Europe Amlodipine Besylate Estimates and Projections (2021-2026)
    10.6 Asia Pacific Amlodipine Besylate Estimates and Projections (2021-2026)
    10.7 Latin America Amlodipine Besylate Estimates and Projections (2021-2026)
    10.8 Middle East and Africa Amlodipine Besylate Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Amlodipine Besylate Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Amlodipine Besylate Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Amlodipine Besylate Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Amlodipine Besylate Manufacturers Covered in This Study Table 5. Global Amlodipine Besylate Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Amlodipine Besylate Sales Share by Manufacturers (2015-2020) Table 7. Global Amlodipine Besylate Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Amlodipine Besylate Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Amlodipine Besylate Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Amlodipine Besylate Sales Sites and Area Served Table 11. Manufacturers Amlodipine Besylate Product Types Table 12. Global Amlodipine Besylate Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Amlodipine Besylate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amlodipine Besylate as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Amlodipine Besylate Players Table 16. Global Amlodipine Besylate Sales (K MT) by Region (2015-2020) Table 17. Global Amlodipine Besylate Sales Market Share by Region (2015-2020) Table 18. Global Amlodipine Besylate Revenue (Million US$) by Region (2015-2020) Table 19. Global Amlodipine Besylate Revenue Market Share by Region (2015-2020) Table 20. North America Amlodipine Besylate Sales by Country (2015-2020) (K MT) Table 21. North America Amlodipine Besylate Sales Market Share by Country (2015-2020) Table 22. North America Amlodipine Besylate Revenue by Country (2015-2020) (US$ Million) Table 23. North America Amlodipine Besylate Revenue Market Share by Country (2015-2020) Table 24. Europe Amlodipine Besylate Sales by Country (2015-2020) (K MT) Table 25. Europe Amlodipine Besylate Sales Market Share by Country (2015-2020) Table 26. Europe Amlodipine Besylate Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Amlodipine Besylate Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Amlodipine Besylate Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Amlodipine Besylate Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Amlodipine Besylate Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Amlodipine Besylate Revenue Market Share by Region (2015-2020) Table 32. Latin America Amlodipine Besylate Sales by Country (2015-2020) (K MT) Table 33. Latin America Amlodipine Besylate Sales Market Share by Country (2015-2020) Table 34. Latin America Amlodipine Besylate Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Amlodipine Besylate Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Amlodipine Besylate Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Amlodipine Besylate Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Amlodipine Besylate Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Amlodipine Besylate Revenue Market Share by Country (2015-2020) Table 40. Global Amlodipine Besylate Sales (K MT) by Type (2015-2020) Table 41. Global Amlodipine Besylate Sales Share by Type (2015-2020) Table 42. Global Amlodipine Besylate Revenue (Million US$) by Type (2015-2020) Table 43. Global Amlodipine Besylate Revenue Share by Type (2015-2020) Table 44. Global Amlodipine Besylate Price (USD/MT) by Type (2015-2020) Table 45. Global Amlodipine Besylate Sales (K MT) by Application (2015-2020) Table 46. Global Amlodipine Besylate Sales Market Share by Application (2015-2020) Table 47. Global Amlodipine Besylate Sales Growth Rate by Application (2015-2020) Table 48. Pfizer Amlodipine Besylate Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Pfizer Main Product Table 52. Pfizer Recent Development Table 53. Mylan Amlodipine Besylate Corporation Information Table 54. Mylan Corporation Information Table 55. Mylan Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Mylan Main Product Table 57. Mylan Recent Development Table 58. Dr. Reddy's Laboratories Amlodipine Besylate Corporation Information Table 59. Dr. Reddy's Laboratories Corporation Information Table 60. Dr. Reddy's Laboratories Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Dr. Reddy's Laboratories Main Product Table 62. Dr. Reddy's Laboratories Recent Development Table 63. Apotex Amlodipine Besylate Corporation Information Table 64. Apotex Corporation Information Table 65. Apotex Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Apotex Main Product Table 67. Apotex Recent Development Table 68. Teva Pharmaceutical Amlodipine Besylate Corporation Information Table 69. Teva Pharmaceutical Corporation Information Table 70. Teva Pharmaceutical Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Teva Pharmaceutical Main Product Table 72. Teva Pharmaceutical Recent Development Table 73. Cipla Amlodipine Besylate Corporation Information Table 74. Cipla Corporation Information Table 75. Cipla Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Cipla Main Product Table 77. Cipla Recent Development Table 78. Hikma Pharmaceuticals Amlodipine Besylate Corporation Information Table 79. Hikma Pharmaceuticals Corporation Information Table 80. Hikma Pharmaceuticals Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Hikma Pharmaceuticals Main Product Table 82. Hikma Pharmaceuticals Recent Development Table 83. Strides Pharma Amlodipine Besylate Corporation Information Table 84. Strides Pharma Corporation Information Table 85. Strides Pharma Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. Strides Pharma Main Product Table 87. Strides Pharma Recent Development Table 88. Upsher-Smith Laboratories Amlodipine Besylate Corporation Information Table 89. Upsher-Smith Laboratories Corporation Information Table 90. Upsher-Smith Laboratories Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 91. Upsher-Smith Laboratories Main Product Table 92. Upsher-Smith Laboratories Recent Development Table 93. InvaGen Pharmaceuticals Amlodipine Besylate Corporation Information Table 94. InvaGen Pharmaceuticals Corporation Information Table 95. InvaGen Pharmaceuticals Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 96. InvaGen Pharmaceuticals Main Product Table 97. InvaGen Pharmaceuticals Recent Development Table 98. Sun Pharmaceutical Amlodipine Besylate Corporation Information Table 99. Sun Pharmaceutical Corporation Information Table 100. Sun Pharmaceutical Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 101. Sun Pharmaceutical Main Product Table 102. Sun Pharmaceutical Recent Development Table 103. Aurobindo Pharma Amlodipine Besylate Corporation Information Table 104. Aurobindo Pharma Corporation Information Table 105. Aurobindo Pharma Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 106. Aurobindo Pharma Main Product Table 107. Aurobindo Pharma Recent Development Table 108. Lupin Pharmaceuticals Amlodipine Besylate Corporation Information Table 109. Lupin Pharmaceuticals Corporation Information Table 110. Lupin Pharmaceuticals Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 111. Lupin Pharmaceuticals Main Product Table 112. Lupin Pharmaceuticals Recent Development Table 113. Zydus Pharmaceuticals Amlodipine Besylate Corporation Information Table 114. Zydus Pharmaceuticals Corporation Information Table 115. Zydus Pharmaceuticals Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 116. Zydus Pharmaceuticals Main Product Table 117. Zydus Pharmaceuticals Recent Development Table 118. Oxford Pharm Amlodipine Besylate Corporation Information Table 119. Oxford Pharm Corporation Information Table 120. Oxford Pharm Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 121. Oxford Pharm Main Product Table 122. Oxford Pharm Recent Development Table 123. Wockhardt Amlodipine Besylate Corporation Information Table 124. Wockhardt Corporation Information Table 125. Wockhardt Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 126. Wockhardt Main Product Table 127. Wockhardt Recent Development Table 128. Epic Pharma Amlodipine Besylate Corporation Information Table 129. Epic Pharma Corporation Information Table 130. Epic Pharma Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 131. Epic Pharma Main Product Table 132. Epic Pharma Recent Development Table 133. CR Pharmaceutical Amlodipine Besylate Corporation Information Table 134. CR Pharmaceutical Corporation Information Table 135. CR Pharmaceutical Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 136. CR Pharmaceutical Main Product Table 137. CR Pharmaceutical Recent Development Table 138. Alkem Laboratories Amlodipine Besylate Corporation Information Table 139. Alkem Laboratories Corporation Information Table 140. Alkem Laboratories Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 141. Alkem Laboratories Main Product Table 142. Alkem Laboratories Recent Development Table 143. MACLEODS Amlodipine Besylate Corporation Information Table 144. MACLEODS Corporation Information Table 145. MACLEODS Amlodipine Besylate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 146. MACLEODS Main Product Table 147. MACLEODS Recent Development Table 148. Sales Base and Market Concentration Rate of Raw Material Table 149. Key Suppliers of Raw Materials Table 150. Amlodipine Besylate Distributors List Table 151. Amlodipine Besylate Customers List Table 152. Market Key Trends Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 154. Key Challenges Table 155. Global Amlodipine Besylate Sales (K MT) Forecast by Type (2021-2026) Table 156. Global Amlodipine Besylate Sales Market Share Forecast by Type (2021-2026) Table 157. Global Amlodipine Besylate Revenue (Million US$) Forecast by Type (2021-2026) Table 158. Global Amlodipine Besylate Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 159. Global Amlodipine Besylate Sales (K MT) Forecast by Application (2021-2026) Table 160. Global Amlodipine Besylate Revenue (Million US$) Forecast by Application (2021-2026) Table 161. Global Amlodipine Besylate Sales (K MT) Forecast by Region (2021-2026) Table 162. Global Amlodipine Besylate Sales Market Share Forecast by Region (2021-2026) Table 163. Global Amlodipine Besylate Revenue Forecast by Region (2021-2026) (US$ Million) Table 164. Global Amlodipine Besylate Revenue Market Share Forecast by Region (2021-2026) Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Amlodipine Besylate Figure 2. Global Amlodipine Besylate Sales Market Share by Type: 2020 VS 2026 Figure 3. 2.5mg Tablets Product Picture Figure 4. 5mg Tablets Product Picture Figure 5. 10mg Tablets Product Picture Figure 6. Global Amlodipine Besylate Consumption Market Share by Application: 2020 VS 2026 Figure 7. High Blood Pressure Figure 8. Heart Disease Figure 9. Global Amlodipine Besylate Market Size 2015-2026 (US$ Million) Figure 10. Global Amlodipine Besylate Sales Capacity (K MT) (2015-2026) Figure 11. Global Amlodipine Besylate Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Amlodipine Besylate Sales Share by Manufacturers in 2020 Figure 13. Global Amlodipine Besylate Revenue Share by Manufacturers in 2019 Figure 14. The Global 5 and 10 Largest Players: Market Share by Amlodipine Besylate Revenue in 2019 Figure 15. Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 16. Global Amlodipine Besylate Sales Market Share by Region (2015-2020) Figure 17. Global Amlodipine Besylate Sales Market Share by Region in 2019 Figure 18. Global Amlodipine Besylate Revenue Market Share by Region (2015-2020) Figure 19. Global Amlodipine Besylate Revenue Market Share by Region in 2019 Figure 20. North America Amlodipine Besylate Sales Market Share by Country in 2019 Figure 21. North America Amlodipine Besylate Revenue Market Share by Country in 2019 Figure 22. U.S. Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 23. U.S. Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 24. Canada Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 25. Canada Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Europe Amlodipine Besylate Sales Market Share by Country in 2019 Figure 27. Europe Amlodipine Besylate Revenue Market Share by Country in 2019 Figure 28. Germany Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 29. Germany Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. France Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 31. France Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. U.K. Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 33. U.K. Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Italy Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 35. Italy Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Russia Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 37. Russia Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Asia Pacific Amlodipine Besylate Sales Market Share by Region in 2019 Figure 39. Asia Pacific Amlodipine Besylate Revenue Market Share by Region in 2019 Figure 40. China Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 41. China Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Japan Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 43. Japan Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. South Korea Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 45. South Korea Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. India Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 47. India Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Australia Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 49. Australia Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Taiwan Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 51. Taiwan Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Indonesia Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 53. Indonesia Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Thailand Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 55. Thailand Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Malaysia Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 57. Malaysia Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Philippines Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 59. Philippines Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Vietnam Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 61. Vietnam Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Latin America Amlodipine Besylate Sales Market Share by Country in 2019 Figure 63. Latin America Amlodipine Besylate Revenue Market Share by Country in 2019 Figure 64. Mexico Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 65. Mexico Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Brazil Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 67. Brazil Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Argentina Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 69. Argentina Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Middle East and Africa Amlodipine Besylate Sales Market Share by Country in 2019 Figure 71. Middle East and Africa Amlodipine Besylate Revenue Market Share by Country in 2019 Figure 72. Turkey Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 73. Turkey Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Saudi Arabia Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 75. Saudi Arabia Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. U.A.E Amlodipine Besylate Sales Growth Rate (2015-2020) (K MT) Figure 77. U.A.E Amlodipine Besylate Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Sales Market Share of Amlodipine Besylate by Type (2015-2020) Figure 79. Sales Market Share of Amlodipine Besylate by Type in 2019 Figure 80. Revenue Share of Amlodipine Besylate by Type (2015-2020) Figure 81. Revenue Market Share of Amlodipine Besylate by Type in 2019 Figure 82. Global Amlodipine Besylate Sales Growth by Type (2015-2020) (K MT) Figure 83. Global Amlodipine Besylate Sales Market Share by Application (2015-2020) Figure 84. Global Amlodipine Besylate Sales Market Share by Application in 2019 Figure 85. Global Revenue Share of Amlodipine Besylate by Application (2015-2020) Figure 86. Global Revenue Share of Amlodipine Besylate by Application in 2020 Figure 87. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Dr. Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Apotex Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Cipla Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Strides Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Upsher-Smith Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. InvaGen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Zydus Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Oxford Pharm Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Epic Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. CR Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 105. Alkem Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 106. MACLEODS Total Revenue (US$ Million): 2019 Compared with 2018 Figure 107. Price Trend of Key Raw Materials Figure 108. Manufacturing Cost Structure of Amlodipine Besylate Figure 109. Manufacturing Process Analysis of Amlodipine Besylate Figure 110. Amlodipine Besylate Industrial Chain Analysis Figure 111. Channels of Distribution Figure 112. Distributors Profiles Figure 113. Porter's Five Forces Analysis Figure 114. North America Amlodipine Besylate Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 115. North America Amlodipine Besylate Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Europe Amlodipine Besylate Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 117. Europe Amlodipine Besylate Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Latin America Amlodipine Besylate Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 119. Latin America Amlodipine Besylate Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Middle East and Africa Amlodipine Besylate Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 121. Middle East and Africa Amlodipine Besylate Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 122. Asia Pacific Amlodipine Besylate Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 123. Asia Pacific Amlodipine Besylate Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 124. Bottom-up and Top-down Approaches for This Report Figure 125. Data Triangulation Figure 126. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Other Reports by QY Research

Global Cotter Pins Market Research Report 2020

This report focuses on Cotter Pins volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cotter Pins market size by analyzing historical data and future prospect. Regionally, thi...

Global Hacksaws Market Research Report 2020

This report focuses on Hacksaws volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hacksaws market size by analyzing historical data and future prospect. Regionally, this repo...

Global Hex Jam Nuts Market Research Report 2020

This report focuses on Hex Jam Nuts volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hex Jam Nuts market size by analyzing historical data and future prospect. Regionally, t...

Global Power Brush Sweepers Market Research Report 2020

This report focuses on Power Brush Sweepers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Power Brush Sweepers market size by analyzing historical data and future prospec...

Global Spring Snap Market Research Report 2020

This report focuses on Spring Snap volume and value at global level, regional level and company level. From a global perspective, this report represents overall Spring Snap market size by analyzing historical data and future prospect. Regionally, thi...

Publisher: QY Research